Found: 6
Select item for more details and to access through your institution.
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2023.1284444
- By:
- Publication type:
- Article
Thermodynamic Concepts in the Study of Microbial Populations: Age Structure in Plasmodium falciparum Infected Red Blood Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026690
- By:
- Publication type:
- Article
The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 3, p. 266, doi. 10.1002/hup.2395
- By:
- Publication type:
- Article
Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 91, doi. 10.1111/j.1527-3466.2008.00046.x
- By:
- Publication type:
- Article